CDC Health Advisory – COVID-19 Rebound after Paxlovid Treatment

Published: 05/24/2022

Sources:
  • Centers for Disease Control and Prevention
Relevant To:
  • All Healthcare Organizations

The Centers for Disease Control and Prevention (CDC) has issued a new Health Advisory to update healthcare providers, public health departments, and the public on the potential for recurrence of COVID-19 or “COVID-19 rebound.”

Paxlovid continues to be recommended for early-stage treatment of mild to moderate COVID-19 among persons at high risk for progression to severe disease. Paxlovid treatment helps prevent hospitalization and death due to COVID-19. COVID-19 rebound has been reported to oc

Sign Up for Free Trial